caustino commited on
Commit
ca80245
Β·
verified Β·
1 Parent(s): 08f8390

Update index.html

Browse files
Files changed (1) hide show
  1. index.html +244 -168
index.html CHANGED
@@ -3,17 +3,24 @@
3
  <head>
4
  <meta charset="UTF-8">
5
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
6
- <title>PSDLEF | Pro Se Disability Litigant Empowerment Foundation</title>
7
  <style>
8
  :root {
9
- --bg: #f9f9f6;
10
  --text: #1a1a1a;
11
- --accent: #1e4a5f;
12
  --card-bg: #ffffff;
13
- --border: #e0ded8;
14
- --muted: #555;
15
- --tag-bg: #e8f0f3;
16
- --tag-text: #1e4a5f;
 
 
 
 
 
 
 
17
  }
18
 
19
  * {
@@ -31,81 +38,79 @@
31
  }
32
 
33
  .container {
34
- max-width: 780px;
35
  margin: 0 auto;
36
  }
37
 
38
  /* Header */
39
- .logo-line {
40
- font-size: 0.9rem;
41
- letter-spacing: 0.28em;
42
  text-transform: uppercase;
43
  color: var(--muted);
44
  margin-bottom: 0.25rem;
45
  }
46
 
47
  h1 {
48
- font-size: 2.3rem;
49
  font-weight: 400;
50
- line-height: 1.2;
51
  color: var(--accent);
52
- margin-bottom: 0.25rem;
53
  letter-spacing: -0.01em;
 
54
  }
55
 
56
  .subtitle {
57
  font-size: 1rem;
58
  font-style: italic;
59
  color: var(--muted);
60
- margin-bottom: 2rem;
 
 
 
 
 
61
  border-bottom: 1px solid var(--border);
62
  padding-bottom: 1.2rem;
 
 
 
 
63
  }
64
 
65
  /* Cards */
66
  .card {
67
  background: var(--card-bg);
68
  border: 1px solid var(--border);
69
- border-radius: 6px;
70
- padding: 1.5rem;
71
- margin-bottom: 1.5rem;
72
- box-shadow: 0 1px 3px rgba(0,0,0,0.03);
73
  }
74
 
75
  .card h2 {
76
- font-size: 1.25rem;
77
  font-weight: 400;
78
  color: var(--accent);
79
- margin-bottom: 0.75rem;
80
- letter-spacing: -0.01em;
81
  border-bottom: 1px solid var(--border);
82
  padding-bottom: 0.5rem;
 
 
83
  }
84
 
85
  .card h3 {
86
- font-size: 1rem;
87
  font-weight: 700;
88
- margin: 1rem 0 0.4rem;
89
- color: var(--text);
90
  }
91
 
92
- .card p,
93
- .card li {
94
- font-size: 0.95rem;
95
  color: #333;
96
- margin-bottom: 0.55rem;
97
- }
98
-
99
- .card ul {
100
- list-style-type: "β€” ";
101
- padding-left: 1.2rem;
102
  }
103
 
104
- .card ul li {
105
- margin-bottom: 0.35rem;
106
- }
107
-
108
- /* Table */
109
  .table-wrap {
110
  overflow-x: auto;
111
  margin: 1rem 0;
@@ -114,80 +119,90 @@
114
  table {
115
  width: 100%;
116
  border-collapse: collapse;
117
- font-size: 0.9rem;
118
  }
119
 
120
  th {
121
  text-align: left;
122
  font-weight: 600;
123
- font-size: 0.8rem;
124
- letter-spacing: 0.06em;
125
  text-transform: uppercase;
126
  color: var(--muted);
127
- padding: 0.5rem 0.5rem 0.5rem 0;
128
- border-bottom: 1px solid var(--border);
 
129
  }
130
 
131
  td {
132
- padding: 0.5rem 0.5rem 0.5rem 0;
133
  border-bottom: 1px solid var(--border);
134
  vertical-align: top;
135
  }
136
 
137
- /* Tags */
138
- .tag {
 
 
 
 
139
  display: inline-block;
140
- background: var(--tag-bg);
141
- color: var(--tag-text);
142
- font-size: 0.75rem;
143
- font-weight: 600;
144
  letter-spacing: 0.04em;
145
- padding: 0.2rem 0.6rem;
146
  border-radius: 3px;
147
- margin-right: 0.4rem;
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
148
  margin-bottom: 0.3rem;
149
  }
150
-
151
- .tag-row {
152
- margin: 0.6rem 0 0.8rem;
 
153
  }
154
 
155
- /* Timeline */
156
- .timeline-item {
157
- display: flex;
158
- gap: 0.8rem;
159
- margin-bottom: 0.55rem;
 
160
  }
161
 
162
- .timeline-year {
163
- font-weight: 700;
164
  color: var(--accent);
165
- min-width: 2.2rem;
166
- font-size: 0.9rem;
167
  }
168
 
169
  /* Footer */
170
  footer {
171
  text-align: center;
172
- font-size: 0.8rem;
173
  color: var(--muted);
174
  margin-top: 2rem;
175
- padding-top: 1rem;
176
  border-top: 1px solid var(--border);
177
  }
178
 
179
- @media (max-width: 500px) {
180
- body {
181
- padding: 1rem 0.5rem;
182
- }
183
-
184
- h1 {
185
- font-size: 1.6rem;
186
- }
187
-
188
- .card {
189
- padding: 1rem;
190
- }
191
  }
192
  </style>
193
  </head>
@@ -195,123 +210,184 @@
195
  <div class="container">
196
 
197
  <!-- Header -->
198
- <div class="logo-line">Perpetual Purpose Trust</div>
199
- <h1>PSDLEF</h1>
200
- <div class="subtitle">Pro Se Disability Litigant Empowerment Foundation<br>$300M Endowment &bull; DYREO Algorithm &bull; 300-House Baltimore Initiative</div>
201
-
202
- <!-- 1. Mission & Model -->
203
- <div class="card">
204
- <h2>1. Mission &amp; Model</h2>
205
- <p>The PSDLEF bridges the accessibility gap for pro se disability litigants by combining <strong>AI-driven legal scaffolding</strong>, neurodiversity-informed advocacy, and a self-sustaining social-impact endowment. The foundation never solicits ongoing donationsβ€”its $300,000,000 corpus, governed by the DYREO Algorithm, permanently funds all operations.</p>
206
-
207
- <h3>Core Services</h3>
208
- <ul>
209
- <li><strong>Legal Scaffolding:</strong> Automated, court-compliant generation of pleadings, writs, and petitions tailored to ADA, Section 504, and constitutional claims.</li>
210
- <li><strong>Neurodiversity Advocacy:</strong> Ethical integration of polygenic risk scores and neurogenomic evidence into accommodation cases.</li>
211
- <li><strong>Resource Center:</strong> Disability-inclusive court navigation tools, on-demand training modules, and a peer advocacy network.</li>
212
- </ul>
213
- <div class="tag-row">
214
- <span class="tag">ADA Title II/III</span>
215
- <span class="tag">Section 504</span>
216
- <span class="tag">Constitutional Claims</span>
217
- <span class="tag">PRS-Informed</span>
218
- <span class="tag">Pro Se</span>
219
- </div>
220
  </div>
221
 
222
- <!-- 2. DYREO Funding Engine -->
223
  <div class="card">
224
- <h2>2. The DYREO Funding Engine</h2>
225
- <p>The <strong>Dynamic Yield &amp; Real Estate Optimization (DYREO) Algorithm</strong> autonomously manages the endowment across three tiers, blending financial security with mandated social utility.</p>
226
-
227
  <div class="table-wrap">
228
  <table>
229
  <thead>
230
- <tr>
231
- <th>Tier</th>
232
- <th>Allocation</th>
233
- <th>Assets</th>
234
- </tr>
235
  </thead>
236
  <tbody>
237
- <tr>
238
- <td><strong>Core Real Assets</strong></td>
239
- <td>40% ($120M)</td>
240
- <td>300 Baltimore rowhomes (solar+battery microgrid), net-lease green commercial property</td>
241
- </tr>
242
- <tr>
243
- <td><strong>Impact Securities</strong></td>
244
- <td>45% ($135M)</td>
245
- <td>Green muni bonds, ESG sovereign debt, fossil-free low-vol equity ETFs</td>
246
- </tr>
247
- <tr>
248
- <td><strong>Liquidity Reserve</strong></td>
249
- <td>15% ($45M)</td>
250
- <td>Money markets, short-term Treasuries β€” covering 3–5 years of operating expenses</td>
251
- </tr>
252
  </tbody>
253
  </table>
254
  </div>
255
-
256
- <p><strong>Yield Target:</strong> 5–7% net annually, generating $15M–$21M for operations.<br>
257
- <strong>Rebalancing:</strong> Quarterly, with strict fossil-fuel and ADA-violator exclusion screens.</p>
258
  </div>
259
 
260
- <!-- 3. 300-House Baltimore Municipal Initiative -->
261
  <div class="card">
262
- <h2>3. The 300-House Baltimore Municipal Initiative</h2>
263
- <p>This signature asset lives inside Tier I and serves dual functions.</p>
 
 
 
 
 
 
 
 
 
 
264
 
265
- <h3>Investment Yield</h3>
266
- <p>300 scattered-site rowhouses retrofitted with rooftop solar and behind-the-meter battery storage, forming a decentralized virtual power plant. Tenant electric subscriptions and grid energy export generate a projected <strong>$2.4M–$3.6M/year</strong> in stable, inflation-hedged revenue.</p>
 
 
 
 
 
 
 
 
 
 
 
 
 
267
 
268
- <h3>Resource Security</h3>
269
- <p>Climate-resilient, microgrid-connected housing is provided to qualifying PSDLEF program participants facing housing instability during active litigation. Uninterrupted power ensures medical devices, communication tools, and e-filing access remain operational during grid outages.</p>
 
 
 
 
 
 
 
 
 
 
 
 
 
270
 
271
- <div class="tag-row">
272
- <span class="tag">Baltimore Rowhomes</span>
273
- <span class="tag">Solar + Battery</span>
274
- <span class="tag">Virtual Power Plant</span>
275
- <span class="tag">Climate-Resilient</span>
276
- </div>
277
- </div>
 
 
 
 
 
 
 
 
 
 
 
 
 
278
 
279
- <!-- 4. Governance & Transparency -->
280
- <div class="card">
281
- <h2>4. Governance &amp; Transparency</h2>
282
- <p>PSDLEF operates as a <strong>perpetual purpose trust</strong> with a Board of Stewards and an independent Trust Protector. The endowment is legally sequestered from any commercial or political entity.</p>
283
- <ul>
284
- <li><strong>DYREO Oversight:</strong> An Algorithmic Audit Committee reviews all rebalancing for fiduciary and ethical compliance; the codebase is open-source.</li>
285
- <li><strong>Annual Impact Report:</strong> Published open-access, combining audited financials (endowment performance, 300-house yield) with litigant-outcome metrics (pleadings generated, pro se win rate benchmarked nationally, housing stability correlated to case outcomes).</li>
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
286
  </ul>
287
  </div>
288
 
289
- <!-- 5. Implementation -->
290
  <div class="card">
291
- <h2>5. Implementation at a Glance</h2>
292
- <div class="timeline-item">
293
- <div class="timeline-year">Year 1</div>
294
- <div>Trust indenture finalized; DYREO codebase audited; first 75 homes acquired; legal scaffolding MVP launches.</div>
295
- </div>
296
- <div class="timeline-item">
297
- <div class="timeline-year">Year 2</div>
298
- <div>300-house retrofit and microgrid complete; pleadings library covers all 12 federal circuits.</div>
299
- </div>
300
- <div class="timeline-item">
301
- <div class="timeline-year">Year 3</div>
302
- <div>First full impact report; PRS-informed evidence pathways integrated.</div>
303
- </div>
304
- <div class="timeline-item">
305
- <div class="timeline-year">Year 5</div>
306
- <div>Feasibility study for replication in peer cities funded by surplus yield.</div>
 
 
 
 
 
 
307
  </div>
308
  </div>
309
 
310
  <!-- Footer -->
311
  <footer>
312
- <em>PSDLEF transforms a one-time capital commitment into a permanent civil rights infrastructureβ€”housing that generates revenue, revenue that funds justice, and justice that scales with technology.</em>
313
  <br><br>
314
- &copy; 2026 Pro Se Disability Litigant Empowerment Foundation &mdash; Perpetual Purpose Trust
315
  </footer>
316
 
317
  </div>
 
3
  <head>
4
  <meta charset="UTF-8">
5
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
6
+ <title>MASTER INDEX β€” Portfolio Table of Contents | PSDLEF Technical Package</title>
7
  <style>
8
  :root {
9
+ --bg: #fafaf8;
10
  --text: #1a1a1a;
11
+ --accent: #1e3a4f;
12
  --card-bg: #ffffff;
13
+ --border: #d9d6ce;
14
+ --muted: #5a5a5a;
15
+ --tag-bg: #e6eef3;
16
+ --tag-text: #1e3a4f;
17
+ --flag-bg: #fff3e0;
18
+ --flag-text: #a15813;
19
+ --alert-bg: #fdecea;
20
+ --alert-text: #b71c1c;
21
+ --ok-bg: #e8f5e9;
22
+ --ok-text: #1b5e20;
23
+ --row-stripe: #fcfcf9;
24
  }
25
 
26
  * {
 
38
  }
39
 
40
  .container {
41
+ max-width: 960px;
42
  margin: 0 auto;
43
  }
44
 
45
  /* Header */
46
+ .doc-id {
47
+ font-size: 0.8rem;
48
+ letter-spacing: 0.22em;
49
  text-transform: uppercase;
50
  color: var(--muted);
51
  margin-bottom: 0.25rem;
52
  }
53
 
54
  h1 {
55
+ font-size: 2.2rem;
56
  font-weight: 400;
 
57
  color: var(--accent);
 
58
  letter-spacing: -0.01em;
59
+ margin-bottom: 0.1rem;
60
  }
61
 
62
  .subtitle {
63
  font-size: 1rem;
64
  font-style: italic;
65
  color: var(--muted);
66
+ margin-bottom: 0.5rem;
67
+ }
68
+
69
+ .version-line {
70
+ font-size: 0.8rem;
71
+ color: var(--muted);
72
  border-bottom: 1px solid var(--border);
73
  padding-bottom: 1.2rem;
74
+ margin-bottom: 2rem;
75
+ display: flex;
76
+ justify-content: space-between;
77
+ flex-wrap: wrap;
78
  }
79
 
80
  /* Cards */
81
  .card {
82
  background: var(--card-bg);
83
  border: 1px solid var(--border);
84
+ border-radius: 5px;
85
+ padding: 1.5rem 1.8rem;
86
+ margin-bottom: 1.8rem;
87
+ box-shadow: 0 1px 3px rgba(0,0,0,0.02);
88
  }
89
 
90
  .card h2 {
91
+ font-size: 1.3rem;
92
  font-weight: 400;
93
  color: var(--accent);
 
 
94
  border-bottom: 1px solid var(--border);
95
  padding-bottom: 0.5rem;
96
+ margin-bottom: 1rem;
97
+ letter-spacing: -0.01em;
98
  }
99
 
100
  .card h3 {
101
+ font-size: 1.05rem;
102
  font-weight: 700;
103
+ margin: 1.2rem 0 0.5rem;
104
+ color: #222;
105
  }
106
 
107
+ .card p, .card li {
108
+ font-size: 0.9rem;
 
109
  color: #333;
110
+ margin-bottom: 0.5rem;
 
 
 
 
 
111
  }
112
 
113
+ /* Tables */
 
 
 
 
114
  .table-wrap {
115
  overflow-x: auto;
116
  margin: 1rem 0;
 
119
  table {
120
  width: 100%;
121
  border-collapse: collapse;
122
+ font-size: 0.85rem;
123
  }
124
 
125
  th {
126
  text-align: left;
127
  font-weight: 600;
128
+ font-size: 0.75rem;
129
+ letter-spacing: 0.05em;
130
  text-transform: uppercase;
131
  color: var(--muted);
132
+ padding: 0.55rem 0.5rem;
133
+ border-bottom: 2px solid var(--border);
134
+ background: #fafaf8;
135
  }
136
 
137
  td {
138
+ padding: 0.55rem 0.5rem;
139
  border-bottom: 1px solid var(--border);
140
  vertical-align: top;
141
  }
142
 
143
+ tr:nth-child(even) td {
144
+ background: var(--row-stripe);
145
+ }
146
+
147
+ /* Badges */
148
+ .badge {
149
  display: inline-block;
150
+ font-size: 0.7rem;
151
+ font-weight: 700;
 
 
152
  letter-spacing: 0.04em;
153
+ padding: 0.2rem 0.55rem;
154
  border-radius: 3px;
155
+ text-transform: uppercase;
156
+ white-space: nowrap;
157
+ }
158
+ .badge-novel { background: #e8e0f0; color: #4a2c6e; }
159
+ .badge-pending { background: var(--flag-bg); color: var(--flag-text); }
160
+ .badge-verified { background: var(--ok-bg); color: var(--ok-text); }
161
+ .badge-alert { background: var(--alert-bg); color: var(--alert-text); }
162
+ .badge-volume { background: var(--tag-bg); color: var(--tag-text); }
163
+
164
+ /* Lists */
165
+ ul.nested {
166
+ list-style-type: none;
167
+ padding-left: 0;
168
+ }
169
+ ul.nested li {
170
+ padding-left: 1.2rem;
171
+ text-indent: -1.2rem;
172
  margin-bottom: 0.3rem;
173
  }
174
+ ul.nested li::before {
175
+ content: "β–Ή ";
176
+ color: var(--accent);
177
+ font-size: 0.8rem;
178
  }
179
 
180
+ /* Timeline / Reading Path */
181
+ .path-box {
182
+ border-left: 3px solid var(--accent);
183
+ padding-left: 1rem;
184
+ margin: 0.8rem 0;
185
+ background: #fdfdfb;
186
  }
187
 
188
+ .path-box strong {
 
189
  color: var(--accent);
 
 
190
  }
191
 
192
  /* Footer */
193
  footer {
194
  text-align: center;
195
+ font-size: 0.75rem;
196
  color: var(--muted);
197
  margin-top: 2rem;
198
+ padding-top: 1.2rem;
199
  border-top: 1px solid var(--border);
200
  }
201
 
202
+ @media (max-width: 600px) {
203
+ body { padding: 1rem 0.3rem; }
204
+ h1 { font-size: 1.5rem; }
205
+ .card { padding: 1rem; }
 
 
 
 
 
 
 
 
206
  }
207
  </style>
208
  </head>
 
210
  <div class="container">
211
 
212
  <!-- Header -->
213
+ <div class="doc-id">PSDLEF-TP-001-MASTER-INDEX</div>
214
+ <h1>MASTER INDEX β€” PORTFOLIO TABLE OF CONTENTS</h1>
215
+ <div class="subtitle">Pro Se Disability Litigant Empowerment Foundation β€” Technical Package</div>
216
+ <div class="version-line">
217
+ <span>Revision 2.0 &bull; July 2026</span>
218
+ <span>Unified Canonical Numbering Active</span>
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
219
  </div>
220
 
221
+ <!-- PART A: Portfolio Overview -->
222
  <div class="card">
223
+ <h2>PART A: PORTFOLIO OVERVIEW AND NAVIGATION</h2>
 
 
224
  <div class="table-wrap">
225
  <table>
226
  <thead>
227
+ <tr><th>Vol</th><th>Title</th><th>Primary Content</th><th>Reviewer Audience</th></tr>
 
 
 
 
228
  </thead>
229
  <tbody>
230
+ <tr><td><span class="badge badge-volume">I</span></td><td>Executive Summary</td><td>Overview, Master Index, Authority Matrix</td><td>Clerks, Staff Attorneys, Initial Reviewers</td></tr>
231
+ <tr><td><span class="badge badge-volume">II</span></td><td>Scientific Dissertation</td><td>Peer-reviewed research, methodology, reproducibility</td><td>Scientific Experts, Amici</td></tr>
232
+ <tr><td><span class="badge badge-volume">III</span></td><td>Security &amp; Zero Trust</td><td>PQC Architecture, Secure Enclave, Merkle DAG Ledger</td><td>CISOs, Security Auditors</td></tr>
233
+ <tr><td><span class="badge badge-volume">IV</span></td><td>Software Architecture</td><td>R Package Architecture, COBOL Controller, REST API</td><td>Technical Experts, IT Specialists</td></tr>
234
+ <tr><td><span class="badge badge-volume">V</span></td><td>Regulatory</td><td>FDA Software Lifecycle, Design Controls, Traceability</td><td>FDA Reviewers, QMS Auditors</td></tr>
235
+ <tr><td><span class="badge badge-volume">VI</span></td><td>Artificial Intelligence</td><td>Scientific Assimilation Engine, XAI, Hallucination Detection</td><td>ML Engineers, Ethics Boards</td></tr>
236
+ <tr><td><span class="badge badge-volume">VII</span></td><td>Reproducibility</td><td>Docker/Nix Builds, Provenance Ledger, FAIR Metadata</td><td>Bioinformaticians, Auditors</td></tr>
237
+ <tr><td><span class="badge badge-volume">VIII</span></td><td>Litigation &amp; Evidence</td><td>Evidence Chain, Exhibit Generation, Expert Witness Workflow</td><td>Court, Opposing Counsel</td></tr>
238
+ <tr><td><span class="badge badge-volume">IX</span></td><td>End-to-End Genomic Pipeline</td><td>23andMe β†’ PRS Engine β†’ Secure Evidence Ledger</td><td>Pipeline Developers, Clinicians</td></tr>
239
+ <tr><td><span class="badge badge-volume">X</span></td><td>Reference Materials</td><td>Master Bibliography, Acronym Index, Glossary</td><td>All Reviewers</td></tr>
 
 
 
 
 
240
  </tbody>
241
  </table>
242
  </div>
243
+ <p style="margin-top:0.5rem;"><em>All volumes use unified canonical identifiers. FIG. 14, TABLE 17, ALG. 4, MOD. 8, PAT. FIG. 14, FDA V&V-14, and EXH. 14 all trace to the same PRS computation concept.</em></p>
 
 
244
  </div>
245
 
246
+ <!-- PART B: Volume I TOC -->
247
  <div class="card">
248
+ <h2>PART B: VOLUME I β€” TABLE OF CONTENTS</h2>
249
+
250
+ <h3>Front Matter</h3>
251
+ <ul class="nested">
252
+ <li>FM-1. Title Page and Portfolio Identifier</li>
253
+ <li>FM-2. Certification of Authenticity and Integrity</li>
254
+ <li>FM-3. Confidentiality Designation and Redaction Index</li>
255
+ <li>FM-4. Master Authority Matrix (CP, SG, DA, SR, LF Domains)</li>
256
+ <li>FM-5. Document Control and Version History</li>
257
+ <li>FM-6. List of Contributing Authors and Affiliations</li>
258
+ <li>FM-7. Correspondence and Service List</li>
259
+ </ul>
260
 
261
+ <h3>Chapter 1: Portfolio Summary and Core Propositions</h3>
262
+ <ul class="nested">
263
+ <li>1.1. Executive Summary of the Scientific Dissertation (Cross-Ref: Vol. II, Ch. 1–4)</li>
264
+ <li>1.2. Summary of Patent Portfolio and Invention Families (Cross-Ref: Vol. III, Spec. 1–N)</li>
265
+ <li>1.3. Overview of Proposed Legal Theories (Cross-Ref: Vol. V, Ch. 2–5)
266
+ <ul class="nested">
267
+ <li>1.3.1. Genomic Information as Property Under Takings Clause <span class="badge badge-novel">Novel Theory</span></li>
268
+ <li>1.3.2. Due Process Implications of AI Accommodation Refusal <span class="badge badge-novel">Novel Theory</span></li>
269
+ <li>1.3.3. SSA Obligation to Accept AI-Based Accommodation <span class="badge badge-novel">Novel Theory</span></li>
270
+ <li>1.3.4. USCIT Jurisdiction Over Post-Quantum Hardware and International Standards Claims <span class="badge badge-novel">Novel Theory</span></li>
271
+ </ul>
272
+ </li>
273
+ <li>1.4. Administrative and Regulatory Context (Cross-Ref: Vol. VI, Regulatory)</li>
274
+ <li>1.5. International Human Rights Framework (Cross-Ref: Vol. IX, Policy Materials)</li>
275
+ </ul>
276
 
277
+ <h3>Chapter 2: Master Cross-Reference Index</h3>
278
+ <ul class="nested">
279
+ <li>2.1. Exhibit Master List (All Volumes)
280
+ <ul class="nested">
281
+ <li>2.1.1. Scientific Exhibits (P-1 through P-NN) [Cross-Ref: Vol. VIII, Scientific Exhibits]</li>
282
+ <li>2.1.2. Legal Exhibits (L-1 through L-NN) [Cross-Ref: Vol. V, App.]</li>
283
+ <li>2.1.3. Administrative Exhibits (A-1 through A-NN) [Cross-Ref: Vol. VI, Admin Record]</li>
284
+ <li>2.1.4. Technical Exhibits (T-1 through T-NN) [Cross-Ref: Vol. IV, Software App.]</li>
285
+ </ul>
286
+ </li>
287
+ <li>2.2. Figure Index (Unified Canonical, Cross-Ref: Vol. X)</li>
288
+ <li>2.3. Table Index (Unified Canonical, Cross-Ref: Vol. X)</li>
289
+ <li>2.4. Algorithm and Code Appendix Index (Cross-Ref: Vol. IV, App. C; Vol. VII, Reproducibility)</li>
290
+ <li>2.5. Authority Identifier Concordance (CP, SG, DA, SR, LF)</li>
291
+ </ul>
292
 
293
+ <h3>Chapter 3: Statistical Claims Verification and Qualification</h3>
294
+ <ul class="nested">
295
+ <li>3.1. Inventory of All Numerical Claims Across Portfolio</li>
296
+ <li>3.2. Status of Supporting Sources
297
+ <ul class="nested">
298
+ <li>3.2.1. Claims with Verified Sources <span class="badge badge-verified">Verified</span></li>
299
+ <li>3.2.2. Claims Requiring Additional Support <span class="badge badge-pending">Flagged</span></li>
300
+ <li>3.2.3. Claims Removed Pending Verification <span class="badge badge-alert">Quarantined</span></li>
301
+ </ul>
302
+ </li>
303
+ <li>3.3. Specific Qualifications:
304
+ <ul class="nested">
305
+ <li>3.3.1. "40% Unaccommodated Error Rate" β€” <span class="badge badge-pending">Under Review; Source Pending</span></li>
306
+ <li>3.3.2. "1.15 Million Americans" β€” <span class="badge badge-pending">Under Review; Source Pending</span></li>
307
+ <li>3.3.3. "60% Increase" β€” <span class="badge badge-pending">Under Review; Source Pending</span></li>
308
+ <li>3.3.4. "30,000 Annual Deaths" β€” <span class="badge badge-pending">Under Review; Source Pending</span></li>
309
+ </ul>
310
+ </li>
311
+ <li>3.4. Methodology for Statistical Validation (Cross-Ref: Vol. II, Statistical Analysis Plan)</li>
312
+ </ul>
313
 
314
+ <h3>Chapter 4: Terminology and Definitions</h3>
315
+ <ul class="nested">
316
+ <li>4.1. Glossary of Technical Terms (Cross-Ref: Vol. X, Glossary)</li>
317
+ <li>4.2. Acronym Index (Cross-Ref: Vol. X, Acronym Index)</li>
318
+ <li>4.3. Defined Legal Terms and Proposed Theories</li>
319
+ <li>4.4. "Phantom Variant OCR Pipelines" β€” <span class="badge badge-pending">Definition Pending</span>
320
+ <ul class="nested">
321
+ <li>4.4.1. Proposed Definition (Pending)</li>
322
+ <li>4.4.2. Supporting Technical Evidence (Cross-Ref: Vol. IV, App. D)</li>
323
+ <li>4.4.3. Alternative: Removal and Substitution with Concrete Description</li>
324
+ </ul>
325
+ </li>
326
+ <li>4.5. "Supported Workflow Components" β€” Clarification: Established tools (BWA, minimap2, GATK, DeepVariant) described as integrated workflow stages orchestrated by an R-based layer; not reimplemented in pure R. (Cross-Ref: Vol. IV, Software Architecture; Vol. VII, Reproducibility)</li>
327
+ </ul>
328
+
329
+ <h3>Chapter 5: Filing Compliance and Procedural Verification</h3>
330
+ <ul class="nested">
331
+ <li>5.1. Applicable Filing Rules and Jurisdictional Requirements
332
+ <ul class="nested">
333
+ <li>5.1.1. SCOTUS Rule 33.1 β€” <span class="badge badge-pending">Jurisdiction and Document Type Under Verification</span></li>
334
+ <li>5.1.2. Lower Court Filing Requirements (If Applicable)</li>
335
+ <li>5.1.3. Administrative Filing Requirements</li>
336
+ </ul>
337
+ </li>
338
+ <li>5.2. Word Count and Formatting Verification Log</li>
339
+ <li>5.3. Word-Limit Compliance Statement (Pending Independent Verification)</li>
340
+ </ul>
341
+
342
+ <h3>Chapter 6: Reading Guide by Reviewer Type</h3>
343
+ <div class="path-box"><strong>Judicial Clerks & Staff Attorneys:</strong> Vols. I β†’ V β†’ VI β†’ VII (Litigation & Administrative Record)</div>
344
+ <div class="path-box"><strong>Scientific Experts & Amici:</strong> Vols. I β†’ II β†’ VIII β†’ IV (Dissertation, Exhibits, Software)</div>
345
+ <div class="path-box"><strong>Technical/IT Reviewers:</strong> Vols. I β†’ IV β†’ VII β†’ III (Software, Reproducibility, Security)</div>
346
+ <div class="path-box"><strong>FDA/Regulatory Reviewers:</strong> Vols. I β†’ V β†’ IV β†’ VII (Regulatory, Software, Reproducibility)</div>
347
+ <div class="path-box"><strong>International Bodies:</strong> Vols. I β†’ IX β†’ II β†’ VIII (Human Rights, Dissertation, Exhibits)</div>
348
+ <div class="path-box"><strong>Patent Examiners & Licensing Counsel:</strong> Vols. I β†’ III (Patent Specs) β†’ IV (Software) β†’ VII (Reproducibility)</div>
349
+
350
+ <h3>Back Matter</h3>
351
+ <ul class="nested">
352
+ <li>BM-1. Master Bibliography by Subject (Abbreviated; Full: Vol. X)</li>
353
+ <li>BM-2. Document Production Log</li>
354
+ <li>BM-3. Errata and Revision Tracking</li>
355
+ <li>BM-4. Contact Information for Portfolio Administrator</li>
356
  </ul>
357
  </div>
358
 
359
+ <!-- PART C: Quick-Reference Cross-Walk -->
360
  <div class="card">
361
+ <h2>PART C: QUICK-REFERENCE CROSS-WALK</h2>
362
+ <div class="table-wrap">
363
+ <table>
364
+ <thead>
365
+ <tr><th>Claim / Term</th><th>Location in Portfolio</th><th>Status</th><th>Authority ID</th></tr>
366
+ </thead>
367
+ <tbody>
368
+ <tr><td>Genomic info = property (Takings)</td><td>Vol. V, Ch. 3; Vol. I, Β§1.3.1</td><td><span class="badge badge-novel">Proposed Theory</span></td><td>[CP-___]</td></tr>
369
+ <tr><td>AI refusal = due process violation</td><td>Vol. V, Ch. 3; Vol. I, Β§1.3.2</td><td><span class="badge badge-novel">Proposed Theory</span></td><td>[DA-___]</td></tr>
370
+ <tr><td>SSA must accept AI accommodation</td><td>Vol. V, Ch. 4; Vol. I, Β§1.3.3</td><td><span class="badge badge-novel">Proposed Theory</span></td><td>[SG-___]</td></tr>
371
+ <tr><td>USCIT jurisdiction (post-quantum)</td><td>Vol. V, Ch. 5; Vol. I, Β§1.3.4</td><td><span class="badge badge-novel">Proposed Theory</span></td><td>[LF-___]</td></tr>
372
+ <tr><td>40% unaccommodated error rate</td><td>Vol. V, App.; Vol. I, Β§3.3.1</td><td><span class="badge badge-pending">Source Pending</span></td><td>[SR-___]</td></tr>
373
+ <tr><td>1.15 million Americans</td><td>Vol. V, App.; Vol. I, Β§3.3.2</td><td><span class="badge badge-pending">Source Pending</span></td><td>[SR-___]</td></tr>
374
+ <tr><td>60% increase</td><td>Vol. V, App.; Vol. I, Β§3.3.3</td><td><span class="badge badge-pending">Source Pending</span></td><td>[SR-___]</td></tr>
375
+ <tr><td>30,000 annual deaths</td><td>Vol. V, App.; Vol. I, Β§3.3.4</td><td><span class="badge badge-pending">Source Pending</span></td><td>[SR-___]</td></tr>
376
+ <tr><td>Phantom variant OCR pipelines</td><td>Vol. IV, App. D; Vol. I, Β§4.4</td><td><span class="badge badge-pending">Definition Pending</span></td><td>[CP-___]</td></tr>
377
+ <tr><td>BWA/minimap2/GATK as supported workflow</td><td>Vol. IV, App. C; Vol. I, Β§4.5</td><td><span class="badge badge-verified">Clarified</span></td><td>[SR-___]</td></tr>
378
+ <tr><td>PRS Workflow (Unified FIG. 14)</td><td>Vol. II, IX; PAT. FIG. 14; EXH. 14</td><td><span class="badge badge-verified">Canonical</span></td><td>[SG-___]</td></tr>
379
+ <tr><td>ML-KEM / ML-DSA / SLH-DSA Registry</td><td>Vol. III, Tables 1–6</td><td><span class="badge badge-verified">Documented</span></td><td>[DA-___]</td></tr>
380
+ <tr><td>FDA Traceability Matrix</td><td>Vol. V, Table 5; FDA V&V-14</td><td><span class="badge badge-verified">Mapped</span></td><td>[LF-___]</td></tr>
381
+ </tbody>
382
+ </table>
383
  </div>
384
  </div>
385
 
386
  <!-- Footer -->
387
  <footer>
388
+ <em>Prepared in accordance with the Master Authority Matrix. Every substantive proposition cross-references its controlling Authority Identifier. Unverified claims are flagged and quarantined pending source confirmation. Established bioinformatics tools are documented as supported workflow components orchestrated by an R-based layer.</em>
389
  <br><br>
390
+ &copy; 2026 Pro Se Disability Litigant Empowerment Foundation β€” Technical Package, Volume I
391
  </footer>
392
 
393
  </div>